179 related articles for article (PubMed ID: 30634104)
1. Geographic variations of multiple sclerosis in Iran: A population based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Mult Scler Relat Disord; 2019 Feb; 28():244-249. PubMed ID: 30634104
[TBL] [Abstract][Full Text] [Related]
2. Incidence of multiple sclerosis in Iran: a nationwide, population-based study.
Hosseinzadeh A; Baneshi MR; Sedighi B; Kermanchi J; Haghdoost AA
Public Health; 2019 Oct; 175():138-144. PubMed ID: 31476710
[TBL] [Abstract][Full Text] [Related]
3. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study.
Khosravi Shadmani F; Ayubi E; Khazaei S; Sani M; Mansouri Hanis S; Khazaei S; Soheylizad M; Mansori K
Epidemiol Health; 2017; 39():e2017020. PubMed ID: 28774167
[TBL] [Abstract][Full Text] [Related]
4. Is the sharp increasing trend of multiple sclerosis incidence real in Iran?
Hosseinzadeh A; Sedighi B; Kermanchi J; Heidari M; Haghdoost AA
BMC Neurol; 2021 Jan; 21(1):7. PubMed ID: 33407243
[TBL] [Abstract][Full Text] [Related]
5. Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
O'Connell K; Tubridy N; Hutchinson M; McGuigan C
Mult Scler Relat Disord; 2017 Apr; 13():75-80. PubMed ID: 28427707
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Janghorbani M; Shaygannejad V; Ashtari F
Neuroepidemiology; 2006; 27(1):39-44. PubMed ID: 16804333
[TBL] [Abstract][Full Text] [Related]
7. Estimated prevalence and incidence of multiple sclerosis in Iran.
Etemadifar M; Izadi S; Nikseresht A; Sharifian M; Sahraian MA; Nasr Z
Eur Neurol; 2014; 72(5-6):370-4. PubMed ID: 25341473
[TBL] [Abstract][Full Text] [Related]
8. A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study.
Elhami SR; Mohammad K; Sahraian MA; Eftekhar H
Neuroepidemiology; 2011; 36(3):141-7. PubMed ID: 21508646
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prevalence of multiple sclerosis in southeastern Iran.
Moghtaderi A; Rakhshanizadeh F; Shahraki-Ibrahimi S
Clin Neurol Neurosurg; 2013 Mar; 115(3):304-8. PubMed ID: 22717599
[TBL] [Abstract][Full Text] [Related]
10. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry.
Koch-Henriksen N; Hyllested K
Acta Neurol Scand; 1988 Nov; 78(5):369-80. PubMed ID: 3218443
[TBL] [Abstract][Full Text] [Related]
13. Temporal trends of incidence and prevalence of multiple sclerosis in Razavi Khorasan Province, Northeast Iran.
Sarmadi M; Saravani H; Azizi O; Najafi F; Hadei M; Momeni J; Bazrafshan E
Neurol Sci; 2022 Jan; 43(1):583-591. PubMed ID: 33939041
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Multiple Sclerosis in Torbat-e Heydarieh (Northeast of Iran) during 1982-2016.
Moghaddam VK; Sarmadi M; Tatari M; Najafi F; Esmaeili A; Hadei M
Mult Scler Relat Disord; 2018 Aug; 24():184-189. PubMed ID: 30077941
[TBL] [Abstract][Full Text] [Related]
15. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Etemadifar M; Maghzi AH
Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
[TBL] [Abstract][Full Text] [Related]
16. National estimate of multiple sclerosis incidence in France (2001-2007).
Fromont A; Binquet C; Sauleau E; Fournel I; Despalins R; Rollot F; Weill A; Clerc L; Bonithon-Kopp C; Moreau T
Mult Scler; 2012 Aug; 18(8):1108-15. PubMed ID: 22298591
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of multiple sclerosis in Iran: a systematic review.
Etemadifar M; Sajjadi S; Nasr Z; Firoozeei TS; Abtahi SH; Akbari M; Fereidan-Esfahani M
Eur Neurol; 2013; 70(5-6):356-63. PubMed ID: 24192707
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis in Isfahan, Iran.
Saadatnia M; Etemadifar M; Maghzi AH
Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
[TBL] [Abstract][Full Text] [Related]
19. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
Maghzi AH; Ghazavi H; Ahsan M; Etemadifar M; Mousavi S; Khorvash F; Minagar A
Mult Scler; 2010 Mar; 16(3):359-61. PubMed ID: 20086021
[TBL] [Abstract][Full Text] [Related]
20. Ongoing increase in incidence and prevalence of multiple sclerosis in south-eastern Iran: A three decade study.
Moghtaderi A; Shahidi-Pourakbari M; Izadi S; Khosravi A; Hashemzehi Z
Mult Scler Relat Disord; 2023 Mar; 71():104557. PubMed ID: 36857854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]